The treatment of pediatric chronic myelogenous leukemia in the imatinib era
Childhood chronic myelogenous leukemia (CML) is a rare hematologic disease, with limited literature on the methods of treatment. Previously, allogeneic hematopoietic stem cell transplantation (HSCT) was considered the only curative treatment for this disease. Treatment with imatinib, a selective inh...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
Korean Pediatric Society,
2011-03-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|